Benzinga Bulls and Bears: Netflix, Novavax, Intel – the market begins to bounce Benzinga Bulls and Bears: Netflix, Novavax, Intel – and the market begins to bounce

Benzinga examined the preferred stock prospects for many investors during the past week – here is a look at some of our upper stories.

American markets wore this week as president Donald Trump Reduce his position on trade and monetary policy. He pointed out that the customs tariff for Chinese imports could decrease from the current 145 % and confirmed his support for the Federal Reserve President Jerome PowellReducing the investor’s concerns about the independence of the central bank.

The S&P 500 has recovered approximately 80 % of its losses after April, with noticeable gains in technology shares. servicenow now He led a weekly increase by 20 %, while Timing Timing 9.9 % increased after the CEO Elon Musk It announced a decrease in the focus on the Ministry of Governmental efficiency (DOGE).

Despite the assembly, economic indicators indicated caution. The growth of the private sector in the United States slowed to its lowest level in 16 months, and the consumer morale decreased sharply. Inflationes increased, with one year expectations up to 6.5 %, the highest level since 1981, indicating continuous economic uncertainty.

Benzinga provides daily reports on the most popular stocks among investors. Here are some of the most difficult posts last week that deserve another look.

Bulls

“Netflix shares are close to a rise: What is happening?” , By Adam IkerReports that Netflix Inc. Nflx The stocks approached record levels in the wake of strong profits in the first quarter-10.54 billion dollars in revenues and $ 6.61 of the stock profit-paid with a strong subscription and advertising growth, as analysts raise prices of up to 1514 dollars and highlight the company’s isolation from the global customs tariff because of its digital business model.

“Why is the arrow of Therapeutics Summit on Wednesday?” , By Vandana SinghReports that Summit Therapics Inc. SMMT The stocks rose after the partner Akeeso, Inc. She announced that the experience of the third stage of Harmondi 6 has achieved the initial end point, with Evonsimab in addition to chemotherapy, which shows a significant statistical improvement in survival without more progress Beigene Ltd.‘s ONC Liberation and narration Tesllezumab in patients with advanced sink lung cancer.

“Novavax Covid-19 vaccine approaches the fully approval of FDA, the arrows jump”, by Vandana SinghReports that Novavax Inc. Nvax The shares have risen after the company mentioned a request for a biology license, and FDA is awaited after requesting post -marketing data.

For additional upward calls last week, check the following:

Celestica Beats Q1, raises a quick look at “Request”, Slide Shares

Nvidia-backed AI starts “very fast growth”-JPMorgan begins with weight gain

Why Rockket Lab shares rise on Thursday?

Bears

“Intel Q1 profits: the winning of revenues, EPS won, and is in line with the weak guidance, the chips maker plans” quick procedures “to pay efficiency”, by Adam IkerReports that Intel company Intc The shares decreased after the company recorded revenues in the first quarter of $ 12.67 billion and modified profits of 13 cents per share, both of which exceeded the expectations of analysts, but he issued expectations in the second quarter of disappointment of $ 11.2 Tan lip To announce organizational simplification measures and reduce costs to enhance efficiency.

“Amazon’s share classification has been reduced, and the target price is reduced because the definitions create uncertainty”, by Erica ColemanReports that Amazon.com Inc. amzn The stocks fell yet Raymond James analyst Josh Beck The shares from Buy Strong to Outperform and reduced the target price from $ 275 to 195 dollars, citing profit pressure before benefits, taxes, and dictation of customs tariffs and one opposite to the macroeconomic.

“IBM slice though the best Q1: details”, by Erica ColemanReports that International Business Machinery Company. IBM The shares fell despite overcoming the first quarter expectations with $ 1.60 and $ 14.54 billion in revenue, as investors’ reaction to the CEO was Arvind KrishnaWarning that economic uncertainty may lead to customers stopping spending.

For more landing, be sure to see these posts:

ENPHASE Energy shares fall on Wednesday: Why do investors sell shares

The analyst warns that the basics of Meta appear fragile in the Q1 report

T-Mobile shares decreased despite the best report expected: Details

Keep up with all the latest urgent news and commercial ideas through follow -up Banznaga On x.

The image created using artificial intelligence via Midjourney.